| __timestamp | Bristol-Myers Squibb Company | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 2395000 |
| Thursday, January 1, 2015 | 5920000000 | 9057000 |
| Friday, January 1, 2016 | 4940000000 | 40818000 |
| Sunday, January 1, 2017 | 6411000000 | 79309000 |
| Monday, January 1, 2018 | 6345000000 | 134428000 |
| Tuesday, January 1, 2019 | 6148000000 | 175431000 |
| Wednesday, January 1, 2020 | 11143000000 | 130944000 |
| Friday, January 1, 2021 | 10195000000 | 121875000 |
| Saturday, January 1, 2022 | 9509000000 | 115856000 |
| Sunday, January 1, 2023 | 9299000000 | 130009000 |
| Monday, January 1, 2024 | 11159000000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceutical innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, Bristol-Myers Squibb Company (BMY) and Wave Life Sciences Ltd. (WVE) have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Bristol-Myers Squibb consistently allocated substantial resources to R&D, with expenditures peaking in 2020 at over 11 billion dollars. This represents a staggering 145% increase from their 2014 spending. In contrast, Wave Life Sciences, a smaller player, saw its R&D expenses grow from a modest 2.4 million dollars in 2014 to approximately 130 million dollars in 2023, marking an impressive 5,300% increase.
These figures highlight the diverse strategies of a pharmaceutical giant and an emerging biotech firm, each navigating the complex path of drug discovery and development.
Research and Development Investment: Sanofi vs Wave Life Sciences Ltd.
Research and Development Investment: Bristol-Myers Squibb Company vs Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Pharming Group N.V.
R&D Spending Showdown: Bristol-Myers Squibb Company vs Ultragenyx Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Geron Corporation
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Wave Life Sciences Ltd.
Research and Development Expenses Breakdown: Summit Therapeutics Inc. vs Wave Life Sciences Ltd.
R&D Insights: How CRISPR Therapeutics AG and Wave Life Sciences Ltd. Allocate Funds
Supernus Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?